Multiple preclinical and phase I study results presented for AIT-082 at neuroscience meeting Nov. 17, 1998
Oral bisphosphonate effectively treats, prevents corticosteroid-induced bone loss and fractures Nov. 17, 1998
RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition Nov. 16, 1998